Searched for
OTSUKA
Global Markets: Japan's Nikkei retreats from record high as AI rally sparks cautionJapan's Nikkei index pulled back from its record high on Wednesday. Investor caution emerged regarding the rapid rise in AI stocks. Tokyo E...- Tokyo's Nikkei closes above 35,000 for first time since 1990The benchmark Nikkei 225 index rose 1.77 percent, or 608.14 points, to 35,049.86 -- the first time the index has risen above the 35,000 mar...
- Otsuka licenses Mylan subsidiary to bring MDR TB drug delamanid to IndiaMDR TB is on the rise in India which, together with China and Russia, accounts for over half of these cases worldwide, according to a recen...
- Otsuka enters deal with Mylan to bring MDR TB drug to IndiaThe Drug Controller General of India has granted Mylan’s subsidiary approval for the drug, according to a release by the company. The drug,...
- Govt agrees to provide new TB drug to a Bihar girlBedaquiline and Delamanid are considered the drug for patients like the Bihar girl. Both drugs can’t be bought in pharmacies and are availa...
- Health Ministry dragged to court over curbs on TB drugsThe drugs –– Bedaquiline by US drugmaker J&J and Delamanid by Japanese drugmaker Otsuka Pharma –– are the only treatment option for patient...
- Aurobindo gains on USFDA final nod for anti-psychotic tabletsShares of Aurobindo Pharma climbed five per cent today as the company has received final approval from the US health regulator FDA to manuf...
- Claris Lifesciences completes transfer of Speciality Injectable BusinessShareholders of the company approved the transfer along with all employees, assets and liabilities at a consideration not less than its boo...
- Claris to buy-back 14.49 per cent stake for Rs 231.25 crore"The objective of the buy-back is to return surplus cash to the equity shareholders of the company," Claris said in a filing to the BSE.
- Insecticides India Ltd plans to hike product prices by 10-15 per centInsecticides India Ltd (IIL) today said it is planning to increase product prices by 10 to 15 per cent with immediate effect.
- Claris transfers two businesses to Japan JV for Rs 1,050 crClaris will continue to hold a 20 per cent stake in the JV, while Otsuka and Mitsui will hold 60 and 20 per cent in it, respectively, a com...
- Claris Lifesciences gets FIPB nod for Japanese JV, Q1 net down by 29%Ahmedabad-based Claris Lifesciences registered de-growth of 29% in its first quarter ended on 31st March 2013.
- Govt approves 12 FDI proposals worth over Rs 2,609 crThe government today said it has approved 12 FDI proposals, including that of pharma firm Claris Otsuka, totalling over Rs 2,609 crore.
- Claris Lifesciences to invest Rs 900 crore on business growth, pre-payment of debtClaris Lifesciences on Thursday said it will invest Rs 900 crore, which it expects to receive as part of divestment of 80 per cent stake in...
- Claris Lifesciences inks JV with Japanese drug maker Otsuka Pharma & Mitsui for Indian marketAhmedabad-based Claris Lifesciences Limited, India executed agreements for a Joint Venture with two Japan-based drug makers Otsuka Pharmace...
- Claris Lifesciences in talks with Otsuka Pharma to sell injectables business: SourcesShares of Claris have rallied 165 per cent from the start of the year and are currently trading at their lifetime high.
- Insecticides India to set up R&D centre with Japan's Otsuka AgriTechnoAgro-chemical manufacturing company Insecticides India Ltd (IIL) today said it has entered into a joint venture with Japan-based Otsuka Agr...
- Otsuka commences unit's production in RajasthanOtsuka Chemical India (OCIL), a wholly-owned subsidiary of Japanese company Ostuka Chemical Co. Ltd, on Friday announced commencement of pr...
- Now, 3D images in your pocket!It may not be long before we will be able to flaunt three-dimensional images in our mobile phones.
- AllBank-Sompo JV hangs fire pending curbsThe joint venture plan between the Allahabad Bank-led consortium and Sompo Japan Insurance for setting up a general insurance company is st...
Load More
